However, in tumor tissues, C1QC + macrophages receive CSF signaling from both MFAP5 + and FABP5 + fibroblasts, suggesting an immunomodulatory role in CRC (Fig. 6A–D). The gene discussed is MFAP5; the disease is neoplasm.